scholarly journals Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute-phase reactants

2010 ◽  
Vol 63 (1) ◽  
pp. 43-52 ◽  
Author(s):  
Josef S. Smolen ◽  
Daniel Aletaha
Keyword(s):  
Rheumatoid Arthritis ◽  
Acute Phase ◽  
Interleukin 6 ◽  
Acute Phase Reactants ◽  
Disease Remission ◽  
Receptor Inhibition ◽  
Interleukin 6 Receptor

A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis

2011 ◽  
Vol 219 (2) ◽  
pp. 734-736 ◽  
Author(s):  
A.D. Protogerou ◽  
E. Zampeli ◽  
K. Fragiadaki ◽  
K. Stamatelopoulos ◽  
C. Papamichael ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Pilot Study ◽  
Endothelial Dysfunction ◽  
Interleukin 6 ◽  
Aortic Stiffness ◽  
Receptor Inhibition ◽  
Interleukin 6 Receptor

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

The Lancet ◽  
2008 ◽  
Vol 371 (9617) ◽  
pp. 987-997 ◽  
Author(s):  
Josef S Smolen ◽  
Andre Beaulieu ◽  
Andrea Rubbert-Roth ◽  
Cesar Ramos-Remus ◽  
Josef Rovensky ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Interleukin 6 ◽  
Randomised Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Receptor Inhibition ◽  
Interleukin 6 Receptor

The effect of tocilizumab - an interleukin-6 receptor antagonist - on lipid levels in rheumatoid arthritis

2017 ◽  
Author(s):  
Ifigenia Kostoglou-Athanassiou ◽  
Lambros Athanassiou ◽  
Aikaterini Tzanavari ◽  
Charoula Katsavouni ◽  
Markos Kostopoulos ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Receptor Antagonist ◽  
Interleukin 6 ◽  
Lipid Levels ◽  
Interleukin 6 Receptor
Sign in / Sign up

Export Citation Format

Share Document